Search results
Signs and Symptoms of Vulvar Cancer
Health via Yahoo News· 1 day agoLife expectancy for vulvar cancer varies by type, stage, and treatment response. The overall five-year survival rate is 69.6%. Squamous ...
Uterine Cancer Symptoms
Healthline· 3 days agoSymptoms of uterine cancer include abnormal uterine bleeding, unusual vaginal discharge, and pelvic pain. Uterine cancer begins in the uterus, also...
TikTok star Kimberley Nix announces her own death in heartbreaking farewell video
NY Post via Yahoo News· 6 days ago"Hello followers, if you're seeing this message I have passed away peacefully," the late social...
Streamlining Access to Cancer Care Saves Lives
NBC Washington· 3 days agoHealthcare professionals across the country continue to work diligently to advance cancer care and improve survival rates, and much progress has been...
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 24 hours agoThe NCI is sponsoring an ongoing randomized ...durvalumab maintenance treatment. The primary endpoint of the trial is progression-free survival, and the trial is designed ...
Verastem (NASDAQ:VSTM) Upgraded to “Hold” by StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com upgraded shares of Verastem (NASDAQ:VSTM – Free Report) from a sell rating to a hold rating in a research report released on Monday morning. Several other research firms also recently ...
PDS Biotechnology Corp. (NASDAQ:PDSB) Uses Cancer Immunotherapy to Infiltrate and Disable Tumors...
The Wall Street Transcript· 2 days agoPDS Biotechnology is a mid- to late-stage clinical development company working in the area of cancer...
...Intensity Therapeutics, Inc. and The Swiss Group for ClinicalCancer Research SAKK Sign a...
FOX 4 Kansas City· 6 days agoIntensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...
B. Riley Weighs in on Verastem, Inc.’s FY2027 Earnings (NASDAQ:VSTM)
ETF DAILY NEWS· 2 days agoVerastem, Inc. (NASDAQ:VSTM – Free Report) – Analysts at B. Riley boosted their FY2027 earnings per share (EPS) estimates for shares of Verastem in a research note issued to investors on Thursday ...
